Anderson, VM; Fernando, KTM; Davies, GR; Rashid, W; Frost, C; Fox, NC; (2007) Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: A comparison of registration-based methods. Journal of neuroimaging, 17 (1). pp. 61-68. ISSN 1051-2284 DOI: https://doi.org/10.1111/j.1552-6569.2006.00081.x Full text not available from this repository.

Chataway, J; Porter, B; Riazi, A; Heaney, D; Watt, H; Hobart, J; Thompson, A; (2006) Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial. Lancet neurology, 5 (7). pp. 565-571. ISSN 1474-4422 DOI: https://doi.org/10.1016/S1474-4422(06)70450-1 Full text not available from this repository.

Hickman, SJ; Kapoor, R; Jones, SJ; Altmann, DR; Plant, GT; Miller, DH; (2003) Corticosteroids do not prevent optic nerve atrophy following optic neuritis. Journal of neurology, neurosurgery, and psychiatry, 74 (8). pp. 1139-41. ISSN 0022-3050 DOI: https://doi.org/10.1136/jnnp.74.8.1139 Full text not available from this repository.

Prosperini, L; Gallo, V; Petsas, N; Borriello, G; Pozzilli, C; (2009) One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis. European journal of neurology, 16 (11). pp. 1202-9. ISSN 1351-5101 DOI: https://doi.org/10.1111/j.1468-1331.2009.02708.x Full text not available from this repository.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2002) Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. Journal of neurology, neurosurgery, and psychiatry, 73 (6). pp. 701-4. ISSN 0022-3050 DOI: https://doi.org/10.1136/jnnp.73.6.701 Full text not available from this repository.